Market Overview

Pfizer Completes License Agreement for Exclusive Commercialization Rights in Europe for CRESEMBA to Treat Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Eurozone Markets

 

Related Articles (PFE + BPMUF)